Abstract:Background: Muscle stem cells (MuSCs) are absolutely required for the formation, repair, and regeneration of skeletal muscle tissue. Increasing evidence demonstrated that tissue stem cells, especially mesenchymal stem cells (MSCs), can exert therapeutic effects on various degenerative and inflammatory disorders based on their immunoregulatory properties. Human mesenchymal stem cells (hMSCs) treated with interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) were reported to possess anti-inflammatory functions by producing TNF-stimulated gene 6 (TSG-6). However, whether human muscle stem cells (hMuSCs) also possess TSG-6 mediated anti-inflammatory functions has not been explored. Methods: The ulcerative colitis mouse model was established by subjecting mice to dextran sulfate sodium (DSS) in drinking water for 7 days. hMuSCs were pretreated with IFN-γ and TNF-α for 48 h and were then transplanted intravenously at day 2 of DSS administration. Body weights were monitored daily. Indoleamine 2,3-dioxygenase (IDO) and TSG-6 in hMuSCs were knocked down with short hairpin RNA (shRNA) and small interfering RNA (siRNA), respectively. Colon tissues were collected for length measurement and histopathological examination. The serum level of IL-6 in mice was measured by enzyme-linked immunosorbent assay (ELISA). Real-time PCR and Western blot analysis were performed to evaluate gene expression. Results: hMuSCs treated with inflammatory factors significantly ameliorated inflammatory bowel disease (IBD) symptoms. IDO and TSG-6 were greatly upregulated and required for the beneficial effects of hMuSCs on IBD. Mechanistically, the tryptophan metabolites, kynurenine (KYN) or kynurenic acid (KYNA) produced by IDO, augmented the expression of TSG-6 through activating their common receptor aryl hydrocarbon receptor (AHR). Conclusion: Inflammatory cytokines-treated hMuSCs can alleviate DSS-induced colitis through IDO-mediated TSG-6 production.

Redressing the interactions between stem cells and immune system in tissue regeneration

Skeletal Muscle Stem Cells Confer Maturing Macrophages Anti-Inflammatory Properties Through Insulin-Like Growth Factor-2.

Combination of inflammation-related cytokines promotes long-term muscle stem cell expansion

Species variations in muscle stem cell-mediated immunosuppression on T cells

Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response

Reciprocal regulation of mesenchymal stem cells and immune responses

MuSCs and IPCs: roles in skeletal muscle homeostasis, aging and injury

Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

IL4I1-catalyzed Tryptophan Metabolites Mediate the Anti-Inflammatory Function of Cytokine-Primed Human Muscle Stem Cells

Inflammatory cytokines-stimulated human muscle stem cells ameliorate ulcerative colitis via the IDO-TSG6 axis

Insight into muscle stem cell regeneration and mechanobiology

Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration.

Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration

A Special Issue on “stem Cell Immunology”

Skeletal Muscle Stem Cells Modulate Niche Function in Duchenne Muscular Dystrophy through YY1-CCL5 Axis

Regulatory T cells in skeletal muscle repair and regeneration: recent insights

Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-[gamma] and TNF-[alpha]

Skeletal Muscle Regeneration is Modulated by Inflammation

Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications

Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases